Next, we investigated the expression status of the Notch-1, β-catenin, STAT3, CD44, and CD24 markers in doxorubicin resistantMCF7 breast cancer cells (MCF7_DoxR) compared to MCF7 parental cells (MCF7_DoxS). This evidence concerns the gene CD44 and breast cancer.